BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bibli SI, Zhou Z, Zukunft S, Fisslthaler B, Andreadou I, Szabo C, Brouckaert P, Fleming I, Papapetropoulos A. Tyrosine phosphorylation of eNOS regulates myocardial survival after an ischaemic insult: role of PYK2. Cardiovasc Res 2017;113:926-37. [PMID: 28444132 DOI: 10.1093/cvr/cvx058] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Murphy JM, Jeong K, Lim SS. FAK Family Kinases in Vascular Diseases. Int J Mol Sci 2020;21:E3630. [PMID: 32455571 DOI: 10.3390/ijms21103630] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
2 Mammedova JT, Sokolov AV, Freidlin IS, Starikova EA. The Mechanisms of L-Arginine Metabolism Disorder in Endothelial Cells. Biochemistry (Mosc) 2021;86:146-55. [PMID: 33832413 DOI: 10.1134/S0006297921020036] [Reference Citation Analysis]
3 de Pins B, Mendes T, Giralt A, Girault JA. The Non-receptor Tyrosine Kinase Pyk2 in Brain Function and Neurological and Psychiatric Diseases. Front Synaptic Neurosci 2021;13:749001. [PMID: 34690733 DOI: 10.3389/fnsyn.2021.749001] [Reference Citation Analysis]
4 Bibli SI, Papapetropoulos A, Iliodromitis EK, Daiber A, Randriamboavonjy V, Steven S, Brouckaert P, Chatzianastasiou A, Kypreos KE, Hausenloy DJ, Fleming I, Andreadou I. Nitroglycerine limits infarct size through S-nitrosation of cyclophilin D: a novel mechanism for an old drug. Cardiovasc Res 2019;115:625-36. [PMID: 30165375 DOI: 10.1093/cvr/cvy222] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 8.5] [Reference Citation Analysis]
5 Köhler D, Bibli SI, Klammer LP, Roth JM, Lehmann R, Fleming I, Granja TF, Straub A, Benz PM, Rosenberger P. Phosphorylation of vasodilator-stimulated phosphoprotein contributes to myocardial ischemic preconditioning. Basic Res Cardiol 2018;113:11. [PMID: 29344719 DOI: 10.1007/s00395-018-0667-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
6 Erkens R, Totzeck M, Brum A, Duse D, Bøtker HE, Rassaf T, Kelm M. Endothelium-dependent remote signaling in ischemia and reperfusion: Alterations in the cardiometabolic continuum. Free Radical Biology and Medicine 2021;165:265-81. [DOI: 10.1016/j.freeradbiomed.2021.01.040] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
7 Li Z, Polhemus DJ, Lefer DJ. Evolution of Hydrogen Sulfide Therapeutics to Treat Cardiovascular Disease. Circ Res 2018;123:590-600. [PMID: 30355137 DOI: 10.1161/CIRCRESAHA.118.311134] [Cited by in Crossref: 38] [Cited by in F6Publishing: 26] [Article Influence: 12.7] [Reference Citation Analysis]
8 Peleli M, Bibli SI, Li Z, Chatzianastasiou A, Varela A, Katsouda A, Zukunft S, Bucci M, Vellecco V, Davos CH, Nagahara N, Cirino G, Fleming I, Lefer DJ, Papapetropoulos A. Cardiovascular phenotype of mice lacking 3-mercaptopyruvate sulfurtransferase. Biochem Pharmacol 2020;176:113833. [PMID: 32027885 DOI: 10.1016/j.bcp.2020.113833] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 8.0] [Reference Citation Analysis]
9 Ma N, Du H, Ma G, Yang W, Han Y, Hu Q, Xiao H. Characterization of the Immunomodulatory Mechanism of a Pleurotus eryngii Protein by Isobaric Tags for Relative and Absolute Quantitation Proteomics. J Agric Food Chem 2020;68:13189-99. [PMID: 32227945 DOI: 10.1021/acs.jafc.0c00219] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Aimo A, Botto N, Vittorini S, Emdin M. Polymorphisms in the eNOS gene and the risk of coronary artery disease: Making the case for genome-wide association studies. Eur J Prev Cardiolog 2019;26:157-9. [DOI: 10.1177/2047487318797402] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
11 Small HY, Guzik TJ. High impact Cardiovascular Research: beyond the heart and vessels. Cardiovasc Res 2019;115:e166-71. [PMID: 31697316 DOI: 10.1093/cvr/cvz272] [Reference Citation Analysis]
12 Farah C, Michel LYM, Balligand JL. Nitric oxide signalling in cardiovascular health and disease. Nat Rev Cardiol 2018;15:292-316. [PMID: 29388567 DOI: 10.1038/nrcardio.2017.224] [Cited by in Crossref: 185] [Cited by in F6Publishing: 171] [Article Influence: 46.3] [Reference Citation Analysis]
13 Tejero J, Shiva S, Gladwin MT. Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation. Physiol Rev 2019;99:311-79. [PMID: 30379623 DOI: 10.1152/physrev.00036.2017] [Cited by in Crossref: 104] [Cited by in F6Publishing: 96] [Article Influence: 34.7] [Reference Citation Analysis]
14 Liu Y, Zhang T, Wen R, Liu C, Yang N, Matsui R. Role of Posttranslational Modifications of Proteins in Cardiovascular Disease. Oxidative Medicine and Cellular Longevity 2022;2022:1-16. [DOI: 10.1155/2022/3137329] [Reference Citation Analysis]
15 Yang X, Li Z, Zhang Y, Bu K, Tian J, Cui J, Qin J, Zhao R, Liu S, Tan G, Liu X. Human urinary kininogenase reduces the endothelial injury by inhibiting Pyk2/MCU pathway. Biomed Pharmacother 2021;143:112165. [PMID: 34543986 DOI: 10.1016/j.biopha.2021.112165] [Reference Citation Analysis]
16 Bibli SI, Szabo C, Chatzianastasiou A, Luck B, Zukunft S, Fleming I, Papapetropoulos A. Hydrogen Sulfide Preserves Endothelial Nitric Oxide Synthase Function by Inhibiting Proline-Rich Kinase 2: Implications for Cardiomyocyte Survival and Cardioprotection. Mol Pharmacol 2017;92:718-30. [PMID: 29030392 DOI: 10.1124/mol.117.109645] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
17 Lee SH, Park CS, Ok SH, Kim D, Kim KN, Hong JM, Kim JY, Bae SI, An S, Sohn JT. Bupivacaine-induced contraction is attenuated by endothelial nitric oxide release modulated by activation of both stimulatory and inhibitory phosphorylation (Ser1177 and Thr495) of endothelial nitric oxide synthase. Eur J Pharmacol 2019;853:121-8. [PMID: 30880179 DOI: 10.1016/j.ejphar.2019.03.026] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
18 Abdelsalam SS, Korashy HM, Zeidan A, Agouni A. The Role of Protein Tyrosine Phosphatase (PTP)-1B in cardiovascular disease and its Interplay with insulin resistance. Biomolecules. 2019;9:286. [PMID: 31319588 DOI: 10.3390/biom9070286] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 10.3] [Reference Citation Analysis]
19 Gheysen L, Soumoy L, Trelcat A, Verset L, Journe F, Saussez S. New Treatment Strategy Targeting Galectin-1 against Thyroid Cancer. Cells 2021;10:1112. [PMID: 34063063 DOI: 10.3390/cells10051112] [Reference Citation Analysis]